Cell Therapy: A New M&A Frontier
Cellares co-founder and CEO Fabian Gerlinghaus shares his unique approach to developing successful cell therapies
Stay up to date on the latest in the middle market with Middle Market Growth’s timely and relevant analysis from editorial staff, guest contributors and industry leaders.